RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Go back to RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $16.54 | |||
| Open | $0.87 | 52 Week Low | $8.10 | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.87 | EPS | $0.00 | |||
| Volume | 44,030 | |||||
